BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28900514)

  • 21. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
    Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.
    Li BS; Zuo QF; Zhao YL; Xiao B; Zhuang Y; Mao XH; Wu C; Yang SM; Zeng H; Zou QM; Guo G
    Oncogene; 2015 May; 34(20):2556-65. PubMed ID: 25043310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1.
    Zhang C; Zou Y; Dai DQ
    Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.
    Xu X; Xia Y; Ma J; Li W; Niu N; Li X; Tao H; Xu J; He X
    Int J Oncol; 2020 Aug; 57(2):522-532. PubMed ID: 32468020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression.
    Han J; Yang Z; Zhao S; Zheng L; Tian Y; Lv Y
    Eur J Clin Invest; 2021 Nov; 51(11):e13592. PubMed ID: 34032284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-135b/CAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling.
    Huangfu L; He Q; Han J; Shi J; Li X; Cheng X; Guo T; Du H; Zhang W; Gao X; Luan F; Xing X; Ji J
    Int J Biol Sci; 2021; 17(8):1940-1952. PubMed ID: 34131397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.
    Zuo QF; Zhang R; Li BS; Zhao YL; Zhuang Y; Yu T; Gong L; Li S; Xiao B; Zou QM
    Cell Death Dis; 2015 Jan; 6(1):e1623. PubMed ID: 25633292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling.
    Wu K; Zou J; Lin C; Jie ZG
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31123165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.
    Chen Z; Liu S; Xia Y; Wu K
    Med Sci Monit; 2016 Dec; 22():4679-4691. PubMed ID: 27904131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
    World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
    Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
    Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
    Yue CF; Li LS; Ai L; Deng JK; Guo YM
    Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated microRNA-7 inhibits proliferation and tumor angiogenesis and promotes apoptosis of gastric cancer cells via repression of Raf-1.
    Lin J; Liu Z; Liao S; Li E; Wu X; Zeng W
    Cell Cycle; 2020 Oct; 19(19):2496-2508. PubMed ID: 32931357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
    Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
    Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.
    Medjkane S; Perez-Sanchez C; Gaggioli C; Sahai E; Treisman R
    Nat Cell Biol; 2009 Mar; 11(3):257-68. PubMed ID: 19198601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1.
    Hu L; Wu H; Wan X; Liu L; He Y; Zhu L; Liu S; Yao H; Zhu Z
    Biochem Biophys Res Commun; 2018 Apr; 499(1):52-58. PubMed ID: 29550487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-936/ERBB4/Akt axis exhibits anticancer properties of gastric cancer through inhibition of cell proliferation, migration, and invasion.
    Liu S; Gong Y; Xu XD; Shen H; Gao S; Bao HD; Guo SB; Yu XF; Gong J
    Kaohsiung J Med Sci; 2021 Feb; 37(2):111-120. PubMed ID: 33021020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.